Este artículo está basado en las fuentes bibliográficas que se citan a continuación, así como en la propia experiencia del Comité de expertos y revisores de Lab Tests Online. Además, este apartado es revisado periódicamente por el Consejo Editorial, con el fin de mantenerlo actualizado.
Los enlaces dirigidos a páginas web pueden no estar disponibles por causas ajenas a nuestra voluntad, por lo que pedimos disculpas y agradeceremos que nos informe de estas anomalías para poder subsanarlas.
Surovi Hazarika, Brian H. Annex. (2017) Biomarkers and Genetics in Peripheral Artery Disease. Clinical Chemistry Jan 2017, 63 (1) 236-244.
Giuseppe Coppolino, Davide Bolignano, Laura Rivoli, et al. (2014) Tumour Markers and Kidney Function: A Systematic Review. BioMed Research International Volume 2014 (2014), Article ID 647541, 9 pages.
Sedighi O, Abediankenari S, Omranifar B. (2015) Association Between Plasma Beta-2 Microglobulin Level and Cardiac Performance in Patients With Chronic Kidney Disease. Nephro-urology Monthly. 2015;7(1):e23563. doi:10.5812/numonthly.23563.
Zeng X, Hossain D, Bostwick DG, Herrera GA, Ballester B, et al. (2014) Urinary β2-Microglobulin is a Sensitive Indicator for Renal Tubular Injury. SAJ Case Rep 1: 103. doi: 10.18875/2375-7043.1.103.
Anita Basu, MD, FACP; Vecihi Batuman, MD, FASNl Reynaldo Matute, MD, et al. (2017) Dialysis-Related Beta-2m Amyloidosis. Disponible online en http://emedicine.medscape.com/article/246542-overview.
Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition: Saunders Elsevier, St. Louis, MO. Pp 742-743.
Basu, A. et. al. Amyloidosis, Beta2M (Dialysis-Related) eMedicine . Disponible online en http://emedicine.medscape.com/article/246542-overview.
Holmes, R. et. al. Amyloidosis, Overview. eMedicine . Disponible online en http://emedicine.medscape.com/article/335414-overview.
Renal Function Markers - Kidney Disease. ARUP Consult . Disponible online en https://arupconsult.com/content/renal-function-markers.
Overview: Beta-2 Microglobulin (B[2]-M), Urine. Mayo Clinic Mayo Medical Laboratories . Disponible online en https://www.mayocliniclabs.com/test-catalog/Overview/602026.
Overview: Beta-2-Microglobulin (Beta-2-M), Serum. Mayo Clinic Mayo Medical Laboratories . Disponible online en https://www.mayocliniclabs.com/test-catalog/Overview/9234.
Amyloidosis and Kidney Disease. National Kidney and Urologic Diseases Information Clearinghouse . Disponible online en https://www.niddk.nih.gov/health-information/community-health-outreach/information-clearinghouses.
Basu, A. et. al. Dialysis-Related Beta-2m Amyloidosis. Medscape Reference . Disponible online en http://emedicine.medscape.com/article/246542-overview.
Gooptu, M. and Scarpaci, A. Beta2-Microglobulin. Medscape Reference . Disponible online en http://emedicine.medscape.com/article/2086864-overview.
Liabeuf, S. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney International (2012) 82, 1297–1303 Abstract. Disponible online en http://www.nature.com/ki/journal/v82/n12/abs/ki2012301a.html.
Amyloidosis and Kidney Disease. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Disponible online en https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis.
Winchester, J. Novel Changes in Beta2-Microglobulin in Dialysis Patients. Clinical Chemistry v 51 (7) 1089-1090 . Disponible online en http://www.clinchem.org/content/51/7/1089.full.
Pagana, K. D. & Pagana, T. J. (© 2011). Mosby's Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pp 680-682.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. 4th edition, St. Louis: Elsevier Saunders; 2006, pg 555.
Rao LV, Pechet L, Jenkins A, et al. Laboratory tests, in Wallach's Interpretation of Diagnostic Tests, 9th ed. (2011) Williamson MA, Snyder ML, eds. Lippincott Williams & Wilkins. Chapter 2.